A diffusion tensor magnetic resonance imaging study of corpus callosum from adult patients with migraine complicated with depressive/anxious disorder

Headache

Volumn 51, Issue 2, 2011, Pages 237-245

  Li, Xian L ^a,b   Fang, Yan N ^a   Gao, Qing C ^b   Lin, Er J ^a   Hu, San H ^a   Ren, Li ^a   Ding, Ming H ^a   Luo, Bo N ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

anxious disorder; corpus callosum; depressive disorder; diffusion tensor magnetic resonance imaging; headache; migraine

Indexed keywords

ADULT; AGED; ANXIETY DISORDER; APPARENT DIFFUSION COEFFICIENT; ARTICLE; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS CALLOSUM; DEPRESSION; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFUSION COEFFICIENT; DIFFUSION TENSOR IMAGING; DISEASE DURATION; FEMALE; FRACTIONAL ANISOTROPY; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HEADACHE; HUMAN; MALE; MIGRAINE; MIGRAINE WITHOUT AURA; NEUROIMAGING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADULT; ANALGESICS; ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; CASE-CONTROL STUDIES; CORPUS CALLOSUM; DEPRESSION; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS;

EID: 79551596799     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2010.01774.x     Document Type: Article

References (44)

1. Breslau N, Merikangas K, Bowden CL,. Comorbidity of migraine and major affective disorders. Neurology. 1994; 44: S17-S22.
2. Breslau N, Davis GC,. Migraine, physical health and psychiatric disorder: A prospective epidemiologic study in young adults. J Psychiatr Res. 1993; 27: 211-221.
3. Rothrock J, Lopez I, Zweilfer R, et al. Borderline personality disorder and migraine. Headache. 2007; 47: 22-26.
4. Radat F, Creac'h C, Guegan-Massardier E, et al. Behavioral dependence in patients with medication overuse headache: A cross-sectional study in consulting patients using the DSM-IV Criteria. Headache. 2008; 48: 1026-1036.
5. Hu XH, Marson LE, Lipton RB, et al. Burden of migraine in the United States: Disability and economic costs. Arch Intern Med. 1999; 159: 813-818.
6. Pesa J, Lage MJ,. The medical costs of migraine and comorbid anxiety and depression. Headache. 2004; 44: 562-570.
7. Fishman P, von Korff M, Lozano P, et al. Chronic care costs in managed care. Health Aff. 1997; 16: 239-247.
8. Breslau N, Lipton RB, Stewart WF, et al. Comorbidity of migraine and depression. Investigating potential etiology and prognosis. Neurology. 2003; 60: 1308-1312.
9. Radat F, Swendsen J,. Psychiatric comorbidity in migraine: A review. Cephalalgia. 2005; 25: 165-178.
10. Peroutka SJ, Price SC, Wilhoit TL, et al. Comorbid migraine with aura, anxiety, and depression is associated with dopamine D2 receptor (DRD2) NcoI alleles. Mol Med. 1998; 4: 14-21.
11. Jarman J, Fernandez M, Davies PT, et al. High incidence of endogenous depression in migraine: Confirmation by tyramine test. J Neurol Neurosurg Psychiatry. 1990; 53: 573-575.
12. Montagna P, Cevoli S, Marzocchi N, et al. The genetics of chronic headaches. Neurol Sci. 2003; 24: S51-S56.
13. Caldecott-Hazard S, Morgan DG, DeLeon-Jones F, et al. Clinical and biochemical aspects of depressive disorders: II. Transmitter/receptor theories. Synapse. 1991; 9: 251-301.
14. Molgat CV, Patten SB,. Comorbidity of major depression and migraine-A Canadian population- based study. Can J Psychiatry. 2005; 50: 832-837.
15. Gomersall JD, Stuart A,. Amitriptyline in migraine prophylaxis: Changes in pattern of attacks during a controlled clinical trial. J Neurol Neurosurg Psychiatry. 1973; 36: 684-690.
16. Couch JR, Hassanein RS,. Amitriptyline in migraine prophylaxis. Arch Neurol. 1979; 36: 695-699.
17. Ziegler DK, Hurwitz A, Hassanein RS, et al. Migraine prophylaxis. A comparison of propranolol and amitriptyline. Arch Neurol. 1987; 44: 486-489.
18. Ziegler DK, Hurwitz A, Preskorn S, et al. Propranolol and amitriptyline in prophylaxis of migraine: Pharmacokinetic and therapeutic effects. Arch Neurol. 1993; 50: 825-830.
19. Adly C, Straumanis J, Chesson A,. Fluoxetine prophylaxis of migraine. Headache. 1992; 32: 101-104.
20. Steiner TJ, Ahmed F, Findley LJ, et al. Fluoxetine in the prophylaxis of migraine: A phase II Double-blind randomized placebo-controlled study. Cephalalgia. 1998; 18: 283-286.
21. d'Amato CC, Pizza V, Marmolo T, et al. Fluoxetine for migraine prophylaxis: A double-blind trial. Headache. 1999; 39: 716-719.
22. Kruit MC, van Buchem MA, Hofman PA, et al. Migraine as a risk factor for subclinical brain lesions. JAMA. 2004; 291: 427-434.
23. Swartz RH, Kern RZ,. Migraine is associated with magnetic resonance imaging white matter abnormalities: A meta-analysis. Arch Neurol. 2004; 61: 1366-1368.
24. Beaulieu C,. The basis of anisotropic water diffusion in the nervous system: A technical review. NMR Biomed. 2002; 15: 435-455.
25. Alexandre FMD, Cristina G, David ST, et al. Interictal alterations of the trigeminal somatosensory pathway and periaqueductal gray matter in migraine. Neuroreport. 2007; 18: 301-305.
26. Burns J, Job D, Bastin ME, et al. Structural disconnectivity in schizophrenia: A diffusion tensor magnetic resonance imaging study. Br J Psychiatry. 2003; 182: 439-443.
27. Ardekani BA, Nierenberg J, Hoptman MJ, et al. MRI study of white matter diffusion anisotropy in schizophrenia. Neuroreport. 2003; 14: 2025-2029.
28. Foong J, Symms MR, Barker GJ, et al. Investigating regional white matter in schizophrenia using diffusion tensor imaging. Neuroreport. 2002; 13: 333-336.
29. Nobuhara K, Okugawa K, Sugimoto T, et al. Frontal white matter anisotropy and symptom severity of late-life depression: A magnetic resonance diffusion tensor imaging study. J Neurol Neurosurg Psychiatry. 2006; 77: 120-122.
30. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders. Cephalagia. 2004; 24: 1-160.
31. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. DSM-IV, 4th edn. Washington, DC: American Psychiatric Association; 1994.
32. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998; 59: 22-33.
33. Hamilton M,. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967; 6: 278-296.
34. Hamilton M,. The assessment of anxiety by rating scale. Br J Med Psychol. 1959; 32: 50-55.
35. Ming YZ,. Psychiatric Rating Scale Manual, Second Edition. Hunan: Hunan (China) Science and Technology Publishing House; 1998.
36. Rotarska-Jagiela A, Schönmeyer R, Oertel V, et al. The corpus callosum in schizophrenia-volume and connectivity changes affect specific regions. Neuroimage. 2008; 39: 1522-1532.
37. Minami T, Nobuhara K, Okugawa G, et al. Diffusion tensor magnetic resonance imaging of disruption of regional white matter in schizophrenia. Neuropsychobiology. 2003; 47: 141-145.
38. Kubicki M, Park H, Westin CF, et al. DTI and MTR abnormalities in schizophrenia: Analysis of white matter integrity. Neuroimage. 2005; 26: 1109-1118. (Pubitemid 40806489)
39. Agartz I, Andersson JL, Skare S,. Abnormal brain white matter in schizophrenia: A diffusion tensor imaging study. Neuroreport. 2001; 12: 2251-2254.
40. Matharu MS, Bartsch T, Ward N, et al. Central neuromodulation in chronic migraine patients with suboccipital stimulators: A PET study. Brain. 2004; 127 (Pt 1): 220-230.
41. Matharu MS, Good CD, May A, et al. No change in the structure of the brain in migraine: A voxel-based morphometric study. Eur J Neurol. 2003; 10: 53-57.
42. Schmidt-Wilcke T, Leinisch E, Straube A, et al. Gray matter decrease in patients with chronic tension type headache. Neurology. 2005; 65: 1483-1486.
43. Rocca MA, Ceccarelli A, Falini A, et al. Brain gray matter changes in migraine patients with T2-visible lesions: A 3-T MRI study. Stroke. 2006; 37: 1765-1770.
44. Kim JH, Suh S-I, Seol HY, et al. Regional grey matter changes in patients with migraine: A voxel-based morphometry study. Cephalalgia. 2008; 28: 598-604.